This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

A Study to Explore the Association Between Blood Pressure, HIV and Antiretroviral Therapy

This study has been completed.
The Hypertension Trust
Information provided by:
Imperial College London Identifier:
First received: August 18, 2005
Last updated: May 27, 2015
Last verified: April 2007
The purpose of this study is to explore the association between blood pressure, HIV and/or its treatment in a cross sectional observational study.

Condition Intervention
HIV Infections Procedure: Blood Pressure Measurement Procedure: Questionnaire

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: A Study to Explore the Association Between Blood Pressure, HIV and Antiretroviral Therapy

Resource links provided by NLM:

Further study details as provided by Imperial College London:

Estimated Enrollment: 3000
Study Start Date: September 2005
Study Completion Date: September 2006
Detailed Description:
Deaths from AIDS have declined dramatically since the introduction of highly active antiretroviral therapy in HIV infected patients. However the incidence of heart disease has increased four-fold and is now one of the major causes of death in HIV infected patients. While HIV drugs are known to adversely affect serum lipids, the evidence concerning the association between raised blood pressure (a major risk for cardiovascular disease) HIV and/or its treatment is limited and conflicting. The researchers believe it of interest to study heart disease risk factors in patients with HIV infection to avoid one premature cause of death (AIDS) being replaced with another potentially preventable cause of death and disability (heart disease). In this cross sectional observational study the researchers will systematically measure blood pressure and other cardiovascular risk factors in HIV positive patients on and off antiretroviral therapy. These individuals will be matched for age, sex and ethnic group with HIV negative individuals.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Attending St. Mary's sexual health outpatient department
  • Patients willing to give written informed consent
  • Ability to communicate in English

Exclusion Criteria:

  • Failure to give written informed consent in English
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00131807

United Kingdom
St. Mary's Hospital
Paddington, London, United Kingdom, W2 1NY
Sponsors and Collaborators
Imperial College London
The Hypertension Trust
Principal Investigator: Neil R Poulter Imperial College London
  More Information Identifier: NCT00131807     History of Changes
Other Study ID Numbers: NPSW03
Study First Received: August 18, 2005
Last Updated: May 27, 2015

Keywords provided by Imperial College London:
Blood Pressure
Antiretroviral therapy

Additional relevant MeSH terms:
HIV Infections
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases processed this record on September 21, 2017